Most read articles by the same author(s)
- Matteo Ruggeri, Francesca Romana Rolli, Cost per response/remission in biologics available in Italy for the treatment of TNF-α inhibitors-naïve patients with ulcerative colitis , Global and Regional Health Technology Assessment: Vol. 6 No. 1 (2019): January-December 2019
- Filippo Rumi, Michele Basile, Americo Cicchetti, Cost-effectiveness and budget impact analysis for high dose quadrivalent influenza vaccine in the Italian elderly population , Global and Regional Health Technology Assessment: Vol. 8 No. 1 (2021): January-December 2021
- Michele Basile, Ilaria Valentini, Roberto Attanasio, Renato Cozzi, Agnese Persichetti, Irene Samperi, Alessandro Scoppola, Renata Simona Auriemma, Ernesto De Menis, Felice Esposito, Emanuele Ferrante, Giuseppe Iatì, Diego Mazzatenta, Maurizio Poggi, Roberta Rudà, Fabio Tortora, Fabio Cruciani, Zuzana Mitrova, Rosella Saulle, Simona Vecchi, Paolo Cappabianca, Agostino Paoletta, Alessandro Bozzao, Marco Caputo, Francesco Doglietto, Francesco Ferraù, Andrea Gerardo Lania, Stefano Laureti, Stefano Lello, Davide Locatelli, Pietro Maffei, Giuseppe Minniti, Alessandro Peri, Chiara Ruini, Fabio Settanni, Antonio Silvani, Nadia Veronese, Franco Grimaldi, Enrico Papini, Americo Cicchetti, A pharmacoeconomic analysis from Italian guidelines for the management of prolactinomas , Global and Regional Health Technology Assessment: Vol. 11 No. 1: January-December 2024
- Michele Basile, Lorenzo Somaini, Americo Cicchetti, Budget Impact Analysis of prolonged-release buprenorphine depot-formulation for the management of patients affected by opioid use disorder , Global and Regional Health Technology Assessment: Vol. 8 No. 1 (2021): January-December 2021
- Filippo Rumi, Michele Basile, Americo Cicchetti, Rosario Contiguglia, Antonella Pentassuglia, Alessandro Oliva, Gianenrico Senna, Marco Bonavia, Francesco Scarpelli, Marco Benvenuto, Introduction of the telemonitoring device Turbo+ in the management of patients suffering from asthma in Italy: a budget impact analysis , Global and Regional Health Technology Assessment: Vol. 9 No. 1 (2022): January-December 2022
- Stefano Fagiuoli, Matteo Ruggeri, Filipa Aragao, Rob Blissett, The Clinical and Economic Benefits of a New Paradigm of HCV Diagnosis and Treatment , Global and Regional Health Technology Assessment: Vol. 8 No. 1 (2021): January-December 2021
- Eugenio Di Brino, Matteo Ruggeri, Stefania Boccia, Nicoletta Cerana, Domenica Lorusso, Dario Sacchini, Antonella Savarese, Liliana Varesco, Americo Cicchetti, A cost-minimization analysis of a preventive testing strategy for relatives of patients with BRCA mutated ovarian cancer , Global and Regional Health Technology Assessment: Vol. 7 No. 1 (2020): January-December 2020
- Michele Basile, Filippo Rumi, Americo Cicchetti, Budget Impact analysis of ponatinib for the management of patients with chronic myeloid leukemia , Global and Regional Health Technology Assessment: Vol. 8 No. 1 (2021): January-December 2021
- Francesco S Mennini, Andrea Marcellusi, Chiara Bini, Maria Assunta Rotundo, Alessandro Giunta, Antonio Gasbarrini, Guido Valesini, Pier Luigi Canonico, Ettore Novellino, Valentina Orlando, Alessandra Mecozzi, Teresa Gamucci, Livio Pagano, Eugenio Di Brino, Matteo Ruggeri, Americo Cicchetti, The economic impact of biosimilars in Italy: a scenario analysis , Global and Regional Health Technology Assessment: Vol. 6 No. 1 (2019): January-December 2019
- Michele Basile, Filippo Rumi, Marco Palmeri, Ivano Mattozzi, Lamberto Manzoli, Massimo Mammuccari, Sergio Gigliotti, Roberto Bernabei, Americo Cicchetti, Economic burden of prescriptive inadequacy in the management of osteoarthritis in Italy , Global and Regional Health Technology Assessment: Vol. 7 No. 1 (2020): January-December 2020